South Korean investigators raid stock exchange in another Samsung BioLogics IPO probe — report
Samsung’s biotech arm is in trouble, again. Prosecutors reportedly raided the office of the Korea Exchange — the bourse on which Samsung BioLogics listed in 2016 — as part of an investigation into the IPO, on Friday.
Regulators suspect the stock market operator softened regulations to allow Samsung BioLogics to list on the exchange. Investigators collected documents and computer hard drives, looking for information related to the 2016 IPO, according to a Nikkei report.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.